The global piperidine market is projected to grow from USD 64 million in 2022 to USD 86 million by 2027, at a CAGR of 5.9% from 2022 to 2027. Piperidine is widely used in crop protection, as an active pharmaceutical ingredient (API) in drug manufacturing, and as a solvent in organic synthesis. The market growth is primarily attributed to the growth in demand for pharmaceutical and agrochemical products. Pharmaceutical demand is growing as a result of changes in clinical practice and the growing demand for drugs for aging-related and chronic diseases. The agrochemical industry has been driven by increasing domestic demand and export demand in various countries.
Piperidine is widely used as intermediates in more than 280 APIs of various therapeutic segments and in the synthesis of pharmaceuticals. In agrochemicals, piperidine is part of the finished active ingredient or they may use as a solvent, base, catalyst, or other processing aid during the manufacturing process. In rubber, industry piperidine is used as curing agent for rubber and epoxy resins. The market growth is attributed to the growing demand of pharmaceutical drugs in the treatment of chronic diseases and drugs for aging-related. In addition, agrochemical demand is increasing pertaining to growing food requirements, improving crop yield, and ensure crop protection.
Get an Exclusive PDF Sample Copy of This Report at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=262881406
On the basis of type the market is segmented into 98% purity and 99% purity. 99% purity segment accounts for greater share than 98% purity segment. This is attributed to its wide application in the pharmaceutical industry. 99% purity is used more to ensure quality control in the pharmaceutical industry.
On the basis of end use industry the market is segmented into agrochemicals, pharmaceutical, rubber, and others. Pharmaceutical end-use industry is projected to account for largest share during the forecast period. This is attributed to the growing prevalence of disease in aging population and the growing diversity of therapeutic drugs.
Asia Pacific is the largest market in the global piperidine market during the forecast period. The large market share in Asia Pacific region is attributed to the increasing demand for pharmaceutical APIs and crop protection chemicals. China and India are the largest market in the Asia Pacific region. The market is growing in these economies pertaining to the growing population, rise in per capita income, governmental investment in healthcare facilities, and better health insurance scheme by the government.
The key players in the piperidine market are BASF SE (Germany), Koei Chemical Co. Ltd. (Japan), Vertellus (US), Jubilant Ingrevia Limited (India), Vasudha Pharma (India), Taj Pharmaceuticals Ltd. (India), Avantor Inc. (US), Allchem Lifescience Pvt. Ltd. (India), Toronto Research Chemicals (Canada), Merck KGaA (Germany), and others. The piperidine market report analyzes the key growth strategies adopted by the leading market players, between 2020 and 2022, which include expansions, mergers & acquisition, new product developments/launch, and collaborations.
Request Customized Report as Per Your Requirements at https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=262881406
Jubilant Ingrevia Limited, a global integrated Life Science products and Innovative Solutions provider. The company operates its business through its specialty chemicals, nutrition & health solution and life science chemicals business segments. The company offers specialty chemicals including acetyl, pyridine, piperidine, ketene, diketene, halogenation & others. Jubilant Ingrevia has a portfolio of more than 100 products. It has five state-of-the-art manufacturing facilities and R&D centers in India. Through its businesses of Specialty Chemicals, Nutrition & Health Solutions and Life Science Chemicals it is serving fast-growing and diverse industries such as pharmaceuticals, agrochemicals, nutrition, consumer and industrial applications.
Vertellus is a U.S. based company and one of the leading player in pyridine, piperidine and picoline manufacturing. It was formerly known as Reilly Industries, Inc. and changed its name to Vertellus Specialties Inc. in July 2006. It was acquired by V Global Holdings LLC (“Vertellus”) in 2016. The company operates its pyridine business through its agriculture and nutrition specialties business unit. The company also manufactures vitamin B3 nutrition products for animal, human, and pharmaceutical uses. The company has 10 manufacturing facilities around the globe, including facilities in the U.S., Europe, China, and India. Vertellus has fully-integrated facilities that cater across the pyridine chemistry value chain. Pritzker Private Capital (PPC), a leader in family direct investing, acquired the Vertellus group of companies in January 2021.
For any Queries Linked with the Report, Ask an Analyst at https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=262881406
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Market Overview Market Research Future (MRFR) has announced a new release on the global Zigbee market.
The report looks into various aspects of the global Zigbee market’s growth in recent years and segmentation, and presents a comprehensive look at the market’s growth prospects over the 2017-2023 forecast period.
According to the report, the global Covid-19 Impact on ZigBee Market is expected to exhibit a strong 8% CAGR over the forecast period.Zigbee is a low-cost, low-power wireless network technology on the lines of Wi-Fi and Bluetooth, but comparatively cheaper than either.
Smart homes have become all the rage in the developed countries in North America and Europe and are likely to remain popular in the coming years due to the convenience they present to the user and the benefits they present in terms of environmental protection and resource conservation.
Smart homes are homes that have underlying connectivity in some form, which allows the users to remotely control various aspects of the house.
Zigbee has become a popular technology in this development, as it presents a cheaper and more efficient alternative to Wi-Fi and Bluetooth.
Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine.
In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years.
[298 Pages Report] The global biomaterials market size is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period.This study involved four major activities in estimating the current size of the biomaterials market.
Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Market DynamicsIncreased funds and grants by government bodies and universities for the development of novel biomaterials Increasing demand for implantable devices Growing demand for biomaterials in plastic surgery and wound healing applicationsRising incidence of cardiovascular diseasesIncreasing research on regenerative medicineCOVID-19 impact on the biomaterials marketCOVID-19 is an infectious disease caused by the most recently discovered novel coronavirus.
With the World Health Organization (WHO) officially declaring the outbreak of COVID-19 a pandemic, a mix of established pharmaceutical and biopharmaceutical companies, as well as small startups, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus.The coronavirus outbreak disrupted business and economic activities globally in the first quarter of 2020.
The report "Covid-19 Impact On Cybersecurity Market by Technology (Network Security, Application Security, Endpoint Security, Cloud Security, Database Security, Web Security, ICS Security), Vertical, Region - Global Forecast to 2021", size is expected to grow from USD 183.2 billion in 2019 to USD 230.0 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 12.0% during the forecast period.
The market growth can be attributed to increasing focus on cybersecurity-driven business continuity plans to provide optimized security to customer data and operations that are being handled by the companies.
Increasing focus on cybersecurity as a critical business imperative and not just as a support function is expected to further drive the market with a higher wallet share for security policies and infrastructure.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128702677Manufacturing vertical to see less growth during the forecast period in the cybersecurity marketAs the COVID-19 crisis continues to expand, manufacturers would likely face challenges on numerous fronts.
Manufacturing companies would be looking for immediate measures to keep their workforces safe and their businesses solvent.
As the COVID-19 pandemic intensifies, manufacturers would likely face continued downward pressure on demand, production, and revenues.
They would also face cash-flow liquidity challenges and difficulties in managing debt obligations.China is the manufacturing hub for almost all raw material requirements across the globe; the COVID-19 pandemic has affected the global economy and disrupted supply chains.
